# Reducing Hemarthrosis in Tibial Tubercle Osteotomy by the Administration of Intravenous Tranexamic Acid

> **NCT03606109** · PHASE4 · COMPLETED · sponsor: **NYU Langone Health** · enrollment: 58 (actual)

## Conditions studied

- Tibial Tubercle Osteotomy

## Interventions

- **DRUG:** Tranexamic Acid (TXA)

## Key facts

- **NCT ID:** NCT03606109
- **Lead sponsor:** NYU Langone Health
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-06-26
- **Primary completion:** 2021-06-02
- **Final completion:** 2021-06-02
- **Target enrollment:** 58 (ACTUAL)
- **Last updated:** 2022-09-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03606109

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03606109, "Reducing Hemarthrosis in Tibial Tubercle Osteotomy by the Administration of Intravenous Tranexamic Acid". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03606109. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*